April 2010

|
Volume 22 Issue 4
ABSTRACT: Myocardial bridging is a common congenital coronary anomaly that is clinically silent in the majority of cases. Case reports suggest myocardial ischemia and infarction can be caused by myocardial bridging. The proposed mechanisms by which m…
Retrograde Approach to a Totally Occluded Right Coronary Artery via a Septal Perforator Artery: The Tale of a Long and Winding Wire ABSTRACT: Retrograde recannalization of chronic total occlusions has developed as a viable alternative to restore co…
Successful Percutaneous Endovascular Management of Acute Post-traumatic Superior Mesenteric Artery Dissection Using a Transradial Approach ABSTRACT: Acute aortic dissection extending into the superior mesenteric artery (SMA) following a blunt trauma…
ABSTRACT: Significant paravalvular aortic regurgitation is among the most important limitations of the interventional revalving techniques for the treatment of severe aortic stenosis. We report on the treatment of a patient with severe paravalvular r…
ABSTRACT: A 7-year-old girl with Williams-Beuren syndrome had undergone multiple percutaneous interventions for resistant peripheral pulmonary arterial stenoses with primarily conventional high-pressure balloon dilatation, but also with use of a cutt…
Anomalous Origin of Right Coronary Artery from Pulmonary Artery and Severe Mitral Regurgitation Due to Myxomatous Mitral Valve Disease: A Case Report and Literature Review ABSTRACT: Anomalous origin of the right coronary artery from the pulmonary a…
ABSTRACT: We present the case of a 54-year-old male with a St. Jude aortic valve replacement who presented with fever and a new diastolic murmur. An echocardiogram identified a pseudoaneurysm that appeared to originate from the left sinus of Valsalva…
ABSTRACT: Background. The recently released Amplatzer Ductal Occluder 2 (ADO2) was designed specifically for use in small children with moderate-sized shunts and larger children with small patent ductus arterioses (PDA). We report our initial experie…
Several devices have been developed over the past four decades for transcatheter occlusion of atrial septal defects (ASD) and patent foramen ovale (PFO) starting with the first reported success in the mid-1970s by King, Mills and their associates.1–…
ABSTRACT: Background. We investigated the safety, feasibility and efficacy of the Occlutech® devices for patent foramen ovale (PFO) and atrial septal defect (ASD) closure in a prospective trial. Methods. The retention discs of the PFO device (23 x 25…